ClinicalTrials.Veeva

Menu

Study on Management Thrombosis in Greek Cancer Patients (GMaT)

H

Hellenic Society of Medical Oncology

Status

Completed

Conditions

Thrombosis

Study type

Observational

Funder types

Other

Identifiers

NCT03292107
Management Thrombosis

Details and patient eligibility

About

Study on Management Thrombosis in Greek cancer patients

Full description

The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline.
  • Age ≥ 18 years
  • Signed informed consent

Exclusion Criteria

  • Initiation of anticoagulation therapy before the initiation of the study in 2016
  • Age <18 years
  • No signed informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems